Omalizumab for the Treatment of Severe Persistent Allergic Asthma in Children Aged 6–11 Years

Overview of attention for article published in PharmacoEconomics, December 2012

Altmetric Badge

About this Attention Score

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 17,334 followers.

Publication: Omalizumab for the treatment of severe and persistent asthma in children aged 6 to 11 years http://t.co/KVkWBLrz

Publication: Omalizumab for the treatment of severe and persistent asthma in children aged 6 to 11 years http://t.co/KVkWBLrz

Omalizumab for the Treatment of Severe Persistent Allergic Asthma in Children Aged 6-11 Years: A NICE Single... http://t.co/w85AGnia

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.